Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00145171
Status:
COMPLETED
Last Update Posted:
2005-09-05
First Post:
2005-09-02
Brief Title:
A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients
Sponsor:
Mylan Bertek Pharmaceuticals
Organization:
Mylan Bertek Pharmaceuticals
Organization Data
Organization:
Mylan Bertek Pharmaceuticals
Class:
INDUSTRY
Study ID:
APO303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mylan Bertek Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None